You are viewing the site in preview mode

Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

  • 1, 4, 5Email author,
  • 1, 4, 5,
  • 1, 3, 4, 5,
  • 1, 4, 5,
  • 1, 4, 5,
  • 2,
  • 2,
  • 2,
  • 2,
  • 3, 4, 5,
  • 1, 4, 5,
  • 6,
  • 3, 4, 5,
  • 3, 4, 5,
  • 2, 4, 5,
  • 2, 4, 5 and
  • 1, 4, 5
Radiation Oncology201813:183

https://doi.org/10.1186/s13014-018-1134-7

  • Received: 17 September 2018
  • Accepted: 17 September 2018
  • Published:

The original article was published in Radiation Oncology 2018 13:159

Correction

Following the publication of this article [1], the authors noticed that Figs. 2, 3, 4 and 5 were in the incorrect order and thus had incorrect captions.
Fig. 2
Fig. 2

Representative example of imaging modalities MRI T1, T2*, and FMISO-PET. Primary tumour and lymph node metastasis (pt. 5, tonsillar carcinoma) at week 0, 2, and 5 (upper, middle, lower panel): co-registered image sets from MRI T1, MRI T2*, FMISO-PET (left to right). Red contours: GTV-T, GTV-LN. Blue contour: HSV-LN

Fig. 3
Fig. 3

Time course of T2* values within volumes. T2* mean ± STD within tumour, lymph nodes and normal tissue for all patients (n = 10)

Fig. 4
Fig. 4

Hypoxic tumour subvolumes: T2* values vs. FDG uptake and FMISO uptake. T2* values (ms) were lower and FDG uptake was higher within hypoxic tumour subvolumes as compared to non-hypoxic tumour subvolumes (*p = 0.051, **p = 0.026). FMISO uptake was higher within hypoxic tumour subvolumes than within non-hypoxic tumour subvolumes (***p = 0.029, p = 0.072, ****p = 0.003, p = 0.0001)

Fig. 5
Fig. 5

Correlation of FMISO uptake with mean T2* and FDG uptake. Plots showing correlation within GTV-T at baseline

The images that were incorrectly published as Figs. 2, 3, 4 and 5 should have been published as Figs. 4, 5, 2 and 3 respectively.

The correct versions of Figs. 2, 3, 4 and 5 with captions have been included in this Correction.

The original article has been corrected.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
(2)
Department of Radiology, Medical Physics, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
(3)
Department of Nuclear Medicine, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
(4)
German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany
(5)
German Cancer Research Center (DKFZ), Heidelberg, Germany
(6)
Clinic for Nuclear Medicine, Technische Universität München, Munich, Germany

Reference

Copyright

© The Author(s). 2018

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement